Contacts:
Alyssa Schaier
Public Relations
(914) 589-6904
Patrick Aysseh, for
Informed Medical Communications
(646) 358-1304
pr_at_informedmedical-dot-com
For Immediate Release:
INFORMED MEDICAL COMMUNICATIONS NETWORK APPOINTS CARL D. BLANDINO CHIEF FINANCIAL
OFFICER TO DRIVE GROWTH AND BOTTOM-LINE RESULTS
New York, NY - January 31, 2005 - Informed Medical
Communications (IMC), an interactive medical marketing group of companies providing
services to the biopharmaceutical industry, announced today the appointment of Carl
D. Blandino as Chief Financial Officer. Based in IMC’s New York office and
reporting directly to Chief Executive Officer, Robert Goodman, Mr. Blandino will
oversee all financial operations and help drive growth of the company.
Mr. Blandino joins the IMC management team with 30 years of financial and operating
experience at both private and public companies. Before joining IMC, he was Chief
Financial Officer/Senior Vice President at Open Solutions Inc. (NASDAQ: Open –
News), a provider of integrated data processing software. At Open Solutions, Mr.
Blandino was instrumental in growing the company from $27 million in revenues to
over $100 million in revenues in just three years. Mr. Blandino also has a strong
background in mergers and acquisitions, initial public offerings and Sarbanes Oxley
compliance. Mr. Blandino has also served as Chief Financial Officer at Online Resources
& Communications Corp., Segue Software, Inc., Per-Se Technologies, and Health Innovations,
Inc. Earlier in his career, he was a Senior Manager at Deloitte Haskins & Sells
and a Manager at Coopers & Lybrand.
“Carl is a high-performance leader in a wide variety of financial responsibilities
including organizational development, investor relations, strategic acquisitions,
initial public offerings, accounting practices and financial forecasting,“
said Mr. Goodman. “His deep experience will be an instrumental asset as we
continue to build our healthcare marketing business through acquisitions and organic
growth,” added Mr. Goodman.
Over the last two years, IMC has grown by 117% from $23 million in Pro Forma revenues
in 2003 to $50 million in revenues for 2005. IMC is a privately held network of
companies that is backed by Ferrer Freeman & Company and Frazier Healthcare Ventures.
“Carl is a seasoned veteran in financial operations with a solid reputation
in the financial community,” noted Alan Frazier of Frazier Healthcare Ventures.
“His expertise will further enhance IMC’s successful track record as
the company continues to grow and make significant strides in the pharmaceutical
marketing arena.”
Mr. Blandino received his B.S. degree in finance and accounting from Robert Morris
University and resides with his wife in Fairfield, Connecticut.
In addition to Mr. Blandino’s appointment, IMC has also engaged PricewaterhouseCoopers
LLP as its independent auditor.
About Informed Medical Communications
Informed Medical Communications (www.informedmedical.com), headquartered in New
York City, is an interactive medical marketing group of companies providing services
to the biopharmaceutical industry. The companies include: The Peer Group, an industry
innovator and leader in conducting peer-to-peer medical programs; HealthTalk, a
pioneer in providing disease information and support resources that empower patients
and caregivers coping with serious medical conditions to proactively and effectively
manage their diseases; RxDialogue, a consumer relationship marketing company designed
to give patients a deeper understanding of benefits and risks of treatment options
in a highly personalized format not provided in traditional advertising; and MRxHealth,
a market research and consulting firm that provides insights into the development
and effectiveness of non-traditional marketing programs for physicians and patients.
The IMC network of companies delivers integrated marketing programs for patients,
physicians, medical professionals and payors, with the goal of improving the dialogue
among patients and physicians in understanding health conditions and their medical
options. IMC is a private-equity backed, privately held company.